| Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ... JAMA neurology 76 (9), 1035-1048, 2019 | 689 | 2019 |
| Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders S Hall, A Öhrfelt, R Constantinescu, U Andreasson, Y Surova, F Bostrom, ... Archives of neurology 69 (11), 1445-1452, 2012 | 510 | 2012 |
| Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder O Hansson, S Janelidze, S Hall, N Magdalinou, AJ Lees, U Andreasson, ... Neurology 88 (10), 930-937, 2017 | 467 | 2017 |
| Cerebrospinal fluid inflammatory markers in Parkinson’s disease–associations with depression, fatigue, and cognitive impairment D Lindqvist, S Hall, Y Surova, HM Nielsen, S Janelidze, L Brundin, ... Brain, behavior, and immunity 33, 183-189, 2013 | 311 | 2013 |
| Non-motor symptoms in patients with Parkinson’s disease–correlations with inflammatory cytokines in serum D Lindqvist, E Kaufman, L Brundin, S Hall, Y Surova, O Hansson Public Library of Science 7 (10), e47387, 2012 | 262 | 2012 |
| CSF biomarkers and clinical progression of Parkinson disease S Hall, Y Surova, A Öhrfelt, H Zetterberg, D Lindqvist, O Hansson Neurology 84 (1), 57-63, 2015 | 242 | 2015 |
| Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease O Hansson, S Hall, A Öhrfelt, H Zetterberg, K Blennow, L Minthon, ... Alzheimer's research & therapy 6, 1-6, 2014 | 234 | 2014 |
| L ongitudinal M easurements of C erebrospinal F luid B iomarkers in P arkinson's D isease S Hall, Y Surova, A Öhrfelt, Swedish BioFINDER Study, K Blennow, ... Movement Disorders 31 (6), 898-905, 2016 | 167 | 2016 |
| Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy M Wennström, Y Surova, S Hall, C Nilsson, L Minthon, F Boström, ... PloS one 8 (1), e53250, 2013 | 156 | 2013 |
| Increased CSF biomarkers of angiogenesis in Parkinson disease S Janelidze, D Lindqvist, V Francardo, S Hall, H Zetterberg, K Blennow, ... Neurology 85 (21), 1834-1842, 2015 | 149 | 2015 |
| Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders S Hall, S Janelidze, Y Surova, H Widner, H Zetterberg, O Hansson Scientific reports 8 (1), 13276, 2018 | 142 | 2018 |
| The inflammatory marker YKL-40 is elevated in cerebrospinal fluid from patients with Alzheimer’s but not Parkinson’s disease or dementia with Lewy bodies M Wennström, Y Surova, S Hall, C Nilsson, L Minthon, O Hansson, ... PloS one 10 (8), e0135458, 2015 | 122 | 2015 |
| Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease JB Pereira, S Hall, M Jalakas, MJ Grothe, O Strandberg, E Stomrud, ... Neurobiology of disease 139, 104831, 2020 | 92 | 2020 |
| Cognitive effects of Lewy body pathology in clinically unimpaired individuals S Palmqvist, M Rossi, S Hall, C Quadalti, N Mattsson-Carlgren, ... Nature Medicine 29 (8), 1971-1978, 2023 | 82 | 2023 |
| Clinical effects of Lewy body pathology in cognitively impaired individuals C Quadalti, S Palmqvist, S Hall, M Rossi, A Mammana, S Janelidze, ... Nature Medicine 29 (8), 1964-1970, 2023 | 80 | 2023 |
| Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease S Hall, CD Orrù, GE Serrano, D Galasko, AG Hughson, BR Groveman, ... Acta neuropathologica communications 10 (1), 90, 2022 | 73 | 2022 |
| Swedish BioFINDER study. Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder O Hansson, S Janelidze, S Hall, N Magdalinou, AJ Lees, U Andreasson, ... Neurology 88 (10), 930-937, 2017 | 67 | 2017 |
| Plasma Phospho‐tau identifies Alzheimer's co‐pathology in patients with Lewy body disease S Hall, S Janelidze, E Londos, A Leuzy, E Stomrud, JL Dage, O Hansson Movement Disorders 36 (3), 767-771, 2021 | 57 | 2021 |
| Proinflammatory cytokines are elevated in serum of patients with multiple system atrophy E Kaufman, S Hall, Y Surova, H Widner, O Hansson, D Lindqvist PLoS One 8 (4), e62354, 2013 | 52 | 2013 |
| The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases R Smith, F Capotosti, M Schain, T Ohlsson, E Vokali, J Molette, ... Nature communications 14 (1), 6750, 2023 | 49 | 2023 |
